Many of these parameters, such as the immunohistochemistry (IHC) expression of estrogen receptor (ER) and progesterone receptor (PgR), HER2 status, tumor stage, lymph node involvement, and Ki67%, are already widely recognized for their prognostic and predictive roles [7]. The gene discussed is PGR; the disease is neoplasm.